Drug Approval | August 09, 2025
Zydus receives final approval from USFDA for Prucalopride Tablets
Prucalopride is prescribed for chronic idiopathic constipation
Prucalopride is prescribed for chronic idiopathic constipation
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
This is the group’s first NoC approval in Canada
Vasograin Plus represents a major advancement in the treatment of migraine
The India Branded Business delivered a 5% YoY growth, reaching Rs. 599 crore in revenue for the quarter
Athena is also exploring the use of this technology for expanded carrier screening
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
Subscribe To Our Newsletter & Stay Updated
